NeuBase Therapeutics, Inc. Restructuring Costs
NeuBase Therapeutics, Inc. reported Restructuring Costs of $365.48 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2023-11-09
- NeuBase Therapeutics, Inc. restructuring costs for the quarter ending 2023-09-30 was $365.48K.
- NeuBase Therapeutics, Inc. restructuring costs for the quarter ending 2023-06-30 was $0.00.
- NeuBase Therapeutics, Inc. restructuring costs for the quarter ending 2023-03-31 was $7.00K.
- NeuBase Therapeutics, Inc. restructuring costs for the quarter ending 2022-12-31 was $700.00K.
| Period end | Restructuring Costs 1 month | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | $365.48K 10-Q · filed 2023-11-09 | $365.48K derived: sum of 2 quarters · filed 2023-11-09 | $372.21K 10-Q · filed 2023-11-09 | $1.07M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $7.00K 10-Q · filed 2023-08-14 | $707.00K derived: sum of 3 quarters · filed 2023-08-14 | ||
| 2023-03-31 | $7.00K 10-Q · filed 2023-05-11 | $707.00K derived: sum of 2 quarters · filed 2023-05-11 | |||
| 2022-12-31 | $700.00K 10-Q · filed 2023-02-14 | ||||
| 2022-10-31 | $700.00K 10-QT · filed 2023-06-05 |